BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kang BW, Kim JG, Kwon OK, Chung HY, Yu W. Non-platinum-based chemotherapy for treatment of advanced gastric cancer: 5-fluorouracil, taxanes, and irinotecan. World J Gastroenterol 2014; 20(18): 5396-5402 [PMID: 24833869 DOI: 10.3748/wjg.v20.i18.5396]
URL: https://www.wjgnet.com/1007-9327/full/v20/i18/5396.htm
Number Citing Articles
1
Hatice YILDIRIM, Ayşe Tuğşen AYDEMİR. Multidrug resistance gene expression response to cisplatin and 5FU treatment in hepatoma, prostate and colon cancer cellsBalıkesir Üniversitesi Fen Bilimleri Enstitüsü Dergisi 2020; 22(2): 698 doi: 10.25092/baunfbed.757286
2
Xinyu Gu, Shuang Li, Xiao Ma, Di Huang, Penghui Li. Heterogeneity characterization of hepatocellular carcinoma based on the sensitivity to 5-fluorouracil and development of a prognostic regression modelFrontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1252805
3
Mi Yea Lee, Min-Jee Kim, Jun-O Jin, Peter Chang-Whan Lee. USP14 inhibition regulates tumorigenesis by inducing apoptosis in gastric cancerBMB Reports 2023; 56(8): 451 doi: 10.5483/BMBRep.2023-0063
4
FEI YUAN, HAILONG SHI, JUN JI, QU CAI, XUEHUA CHEN, YINGYAN YU, BINGYA LIU, ZHENGGANG ZHU, JUN ZHANG. Capecitabine metronomic chemotherapy inhibits the proliferation of gastric cancer cells through anti-angiogenesisOncology Reports 2015; 33(4): 1753 doi: 10.3892/or.2015.3765
5
Qian Liu, Lijuan Guo, Zhiyuan Lou, Xueping Xiang, Jimin Shao. Super-enhancers and novel therapeutic targets in colorectal cancerCell Death & Disease 2022; 13(3) doi: 10.1038/s41419-022-04673-4
6
Jie Ge, Ting Liu, Tianxiang Lei, Xuan Li, Kun Song, Samim Azizi, Heli Liu, Mimi Tang. Retrospective Cohort Study of Intraoperative Administration of Sustained-Release 5-Fluorouracil Implants in Advanced Gastric Cancer PatientsFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.659258
7
Kuo Kang, Xuanxuan Li, Yuanhao Peng, Yangying Zhou. Comprehensive Analysis of Disulfidptosis-Related LncRNAs in Molecular Classification, Immune Microenvironment Characterization and Prognosis of Gastric CancerBiomedicines 2023; 11(12): 3165 doi: 10.3390/biomedicines11123165
8
MASAHIRO INOUE, KAZUNORI OTSUKA, HIROYUKI SHIBATA. Circulating tumor cell count as a biomarker of a specific gastric cancer subgroup characterized by bone metastasis and/or disseminated intravascular coagulation - an early indicator of chemotherapeutic responseOncology Letters 2016; 11(2): 1294 doi: 10.3892/ol.2015.4056
9
Nayla Mouawad, Maguie El Boustani, Vincenzo Canzonieri, Isabella Caligiuri, Flavio Rizzolio. Gastric Cancer In The Precision Medicine EraCurrent Clinical Pathology 2019; : 213 doi: 10.1007/978-3-030-04861-7_13
10
Nebojša Đ. Pantelić, Bojan Božić, Bojana B. Zmejkovski, Nebojša R. Banjac, Biljana Dojčinović, Ludger A. Wessjohann, Goran N. Kaluđerović. In Vitro Evaluation of Antiproliferative Properties of Novel Organotin(IV) Carboxylate Compounds with Propanoic Acid Derivatives on a Panel of Human Cancer Cell LinesMolecules 2021; 26(11): 3199 doi: 10.3390/molecules26113199
11
Tingting Zhao, Zhi Xu, Dongying Gu, Peng Wu, Xinying Huo, Xiaowei Wei, Yongfei Tang, Weida Gong, Ming-Liang He, Jinfei Chen. The effects of genomic polymorphisms in one-carbon metabolism pathways on survival of gastric cancer patients received fluorouracil-based adjuvant therapyScientific Reports 2016; 6(1) doi: 10.1038/srep28019
12
Afzal Hussain, Mohamed Fahad AlAjmi, Prince F. Iqbal, Waseem A. Wani. Combination Therapy Against Multidrug Resistance2020; : 95 doi: 10.1016/B978-0-12-820576-1.00005-9